A single-arm clinical trial to evaluate the efficacy and safety of Simvastatin, Orlistat, and Trimetazidine in combination with second-line treatment drugs for advanced liver cancer

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2023
This article has no abstract
Epistemonikos ID: 17408f55dbecb38bd99c34b7025b9c1b9b92e4b9
First added on: Apr 08, 2025